| Old Articles: <Older 15961-15970 Newer> |
 |
Pharmaceutical Executive March 1, 2013 Ken Getz |
Building Clinical Trial Awareness for Patients: Why Not Try the Pharmacist? The author explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.  |
Pharmaceutical Executive March 1, 2013 Keeling & Paz |
Early Engagement with Medical Laboratories Timely engagement is the key to expanding the use of companion diagnostics.  |
Pharmaceutical Executive March 1, 2013 Al Topin |
Less Selling, More Time What can happen when pharmaceutical reps focus on the physician-patient conversation?  |
Pharmaceutical Executive March 1, 2013 Bonifant & Setrakianis |
Test and Learn: Making Confident Decisions on the Commercial Side Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.  |
Pharmaceutical Executive March 1, 2013 Forcellina & Akannac |
Embedding Market Access in Today's Pharma Business Model A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.  |
Pharmaceutical Executive March 1, 2013 Henninger & Feldstein |
Safeguarding the Value of Patent Assets As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.  |
HBS Working Knowledge March 25, 2013 Kim Girard |
How Chapter 11 Saved the US Economy In a relatively short time, much of the corporate debt that defaulted during the US financial crisis has been managed down and corporate profits have rebounded. Stuart C. Gilson reviews the power of Chapter 11 bankruptcy  |
HBS Working Knowledge March 22, 2013 Dina Gerdeman |
Pulling Campbell's Out of the Soup Campbell Soup had lost its way when Douglas Conant took charge in 2001. His first task: get out of his quiet zone and apply bold measures as a leader.  |
CRM March 19, 2013 Kelly Liyakasa |
Data and Customers Are Top CEO Investment Priorities Executives are most concerned about revenue growth, reducing costs.  |
HBS Working Knowledge March 20, 2013 Dina Gerdeman |
How CEOs Sustain Higher-Ambition Goals At a recent Harvard Business School conference, dozens of CEOs committed to the idea of working toward "higher-ambition" goals that go beyond just short-term shareholder value.  |
| <Older 15961-15970 Newer> Return to current articles. |